BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8884149)

  • 1. Sebum excretion rate in subjects treated with oral all-trans-retinoic acid.
    Hommel L; Geiger JM; Harms M; Saurat JH
    Dermatology; 1996; 193(2):127-30. PubMed ID: 8884149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral 9-cis-retinoic acid versus 13-cis-retinoic acid in acne therapy.
    Ott F; Bollag W; Geiger JM
    Dermatology; 1996; 193(2):124-6. PubMed ID: 8884148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Topical Medication of All-Trans Retinoic Acid Reduces Sebum Excretion Rate in Patients With Forehead Acne.
    Pan J; Wang Q; Tu P
    Am J Ther; 2017; 24(2):e207-e212. PubMed ID: 26872139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral 13-cis retinoic acid is superior to 9-cis retinoic acid in sebosuppression in human beings.
    Geiger JM; Hommel L; Harms M; Saurat JH
    J Am Acad Dermatol; 1996 Mar; 34(3):513-5. PubMed ID: 8609271
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris.
    Domínguez J; Hojyo MT; Celayo JL; Domínguez-Soto L; Teixeira F
    Int J Dermatol; 1998 Jan; 37(1):54-5. PubMed ID: 9522243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tretinoin 0.05% cream and 3% alcohol-based salicylic acid preparation in the treatment of acne vulgaris.
    Babayeva L; Akarsu S; Fetil E; Güneş AT
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):328-33. PubMed ID: 20666879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population.
    King K; Jones DH; Daltrey DC; Cunliffe WJ
    Br J Dermatol; 1982 Nov; 107(5):583-90. PubMed ID: 6215056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral 13-cis-retinoic acid at three dose levels on sustainable rates of sebum secretion and on acne.
    Stewart ME; Benoit AM; Stranieri AM; Rapini RP; Strauss JS; Downing DT
    J Am Acad Dermatol; 1983 Apr; 8(4):532-8. PubMed ID: 6222086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Skin lipids in 13-cis-retinoic acid therapy of acne].
    Schmidt JB; Spona J; Niebauer G
    Z Hautkr; 1983 Dec; 58(24):1743-53. PubMed ID: 6229930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 13-cis retinoic acid and acne.
    Jones H; Blanc D; Cunliffe WJ
    Lancet; 1980 Nov; 2(8203):1048-9. PubMed ID: 6107678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arotinoid Ro 13-6298 and etretin: two new retinoids inferior to isotretinoin in sebum suppression and acne treatment.
    Harms M; Philippe I; Radeff B; Masouyé I; Geiger JM; Saurat JH
    Acta Derm Venereol; 1986; 66(2):149-54. PubMed ID: 2424239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral retinoids in the treatment of seborrhoea and acne.
    Orfanos CE; Zouboulis CC
    Dermatology; 1998; 196(1):140-7. PubMed ID: 9557249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi.
    Anadolu RY; Sen T; Tarimci N; Birol A; Erdem C
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):416-21. PubMed ID: 15196153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 13-cis-retinoic acid on sebum production and Propionibacterium acnes in severe nodulocystic acne.
    Leyden JJ; McGinley KJ
    Arch Dermatol Res; 1982; 272(3-4):331-7. PubMed ID: 6219631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olumacostat Glasaretil, a Promising Topical Sebum-Suppressing Agent that Affects All Major Pathogenic Factors of Acne Vulgaris.
    Melnik BC
    J Invest Dermatol; 2017 Jul; 137(7):1405-1408. PubMed ID: 28647025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial.
    Farrell LN; Strauss JS; Stranieri AM
    J Am Acad Dermatol; 1980 Dec; 3(6):602-11. PubMed ID: 6451637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral isotretinoin. Where now, where next?
    Saurat JH
    Dermatology; 1997; 195 Suppl 1():1-3; discussion 38-40. PubMed ID: 9310738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotretinoin: new therapy for severe acne.
    Perry MD; McEvoy GK
    Clin Pharm; 1983; 2(1):12-9. PubMed ID: 6192964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotretinoin in severe, recalcitrant cystic acne: a review.
    Rumsfield JA; West DP; Tse CS; Eaton ML; Robinson LA
    Drug Intell Clin Pharm; 1983 May; 17(5):329-33. PubMed ID: 6222891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne.
    Laquieze S; Czernielewski J; Rueda MJ
    J Drugs Dermatol; 2006; 5(10):985-90. PubMed ID: 17373148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.